Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1/Caveolin-3/STAT3 signaling in diabetic rats

Diabetes

Volumn 65, Issue 4, 2016, Pages 942-955

  Li, Haobo ^a,b   Yao, Weifeng ^b   Liu, Zipeng ^b   Xu, Aimin ^a,b   Huang, Yu ^a,c   Ma, Xin Liang ^d   Irwin, Michael G ^b   Xia, Zhengyuan ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOR1 PROTEIN; CAVEOLIN 3; PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY OCCLUSION; DIABETES MELLITUS; HEART MUSCLE CELL; HEART PROTECTION; HYPERGLYCEMIA; ISCHEMIC POSTCONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WILD TYPE; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; COMPLICATION; CORONARY BLOOD VESSEL; EXPERIMENTAL DIABETES MELLITUS; KNOCKOUT MOUSE; METABOLISM; MOUSE; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CAVEOLIN 3; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; ISCHEMIC POSTCONDITIONING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84962173653     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0782     Document Type: Article

References (47)

1. Roffi M, Eberli FR Diabetes and acute coronary syndromes. Best Pract Res Clin Endocrinol Metab 2009; 23:305-316
2. Zhao ZQ, Corvera JS, Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285:H579-H588
3. Boengler K, Buechert A, Heinen Y., et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 2008; 102: 131-135
4. Przyklenk K, Maynard M, Greiner D.L., Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 2011; 14:781-790
5. Gross ER, Hsu AK, Gross GJ Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes 2007; 56:127-136
6. Tao L, Gao E, Jiao X., et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007; 115:1408-1416
7. Wang Y, Wang X, Jasmin J.F., et al. Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection. Arterioscler Thromb Vasc Biol 2012; 32:934-942
8. Liao W, Yu C, Wen J., et al. Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Biol Cell 2009; 101:263-272
9. Wang T, Mao X, Li H., et al. N-acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic Biol Med 2013; 63:291-303
10. Yi W, Sun Y, Gao E., et al. Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms. Antioxid Redox Signal 2011; 15:1779-1788
11. Li R, Xu M, Wang X., et al. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance. J Mol Cell Cardiol 2010; 49: 508-515
12. Tan Z, Zhou LJ, Mu P.W., et al. Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats. J Nutr Biochem 2012; 23:1716-1724
13. Lei S, Li H, Xu J., et al. Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling. Diabetes 2013; 62:2318-2328
14. Rice DS, Calandria JM, Gordon W.C., et al. Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival. Nat Commun 2015; 6:6228
15. Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 2013; 17:185-196
16. van Oosten A.L., Costa Y, Smith A., Silva JC. JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat Commun 2012; 3:817
17. Ma K, Cabrero A, Saha P.K., et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 2002; 277:34658-34661
18. Liao XL, Hu XX, Chang F.J., et al. A simple modification results in greater success in the model of coronary artery ligation and myocardial ischemia in mice. J Cardiovasc Pharmacol 2013; 61:430-436
19. Li H, Yao W, Irwin M.G., et al. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free Radic Biol Med 2015; 84:311-321
20. Xu J, Li H, Irwin M.G., et al. Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats. Crit Care Med 2014; 42: e583-e594
21. Li H, Liu Z, Wang J., et al. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc Diabetol 2013; 12:133
22. Lin Z, Wu F, Lin S., et al. Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice. J Hepatol 2014; 61:825-831
23. Xia Z, Kuo KH, Nagareddy P.R., et al. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc Res 2007; 73:770-782
24. Liu Y, Lei S, Gao X., et al. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Clin Sci (Lond) 2012; 122:161-173
25. Yao LL, Huang XW, Wang Y.G., Cao YX, Zhang CC, Zhu YC. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ Physiol 2010; 298:H1310-H1319
26. Shibata R, Sato K, Kumada M., et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc Res 2007; 74:471-479
27. Heusch G, Musiolik J, Gedik N., Skyschally A. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 2011; 109:1302-1308
28. Denzel MS, Scimia MC, Zumstein P.M., Walsh K., Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 2010; 120:4342-4352
29. Berg AH, Combs TP, Scherer PE ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84-89
30. Piñeiro R., Iglesias MJ, Gallego R, et al Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 2005; 579:5163-5169
31. Cohen MV, Downey JM Cardioprotection: spotlight on PKG. Br J Pharmacol 2007; 152:833-834
32. Hausenloy DJ, Tsang A, Yellon DM The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 2005; 15:69-75
33. Skyschally A, van Caster P, Boengler K, et al Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009; 104:15-18
34. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol 2010; 105:151-154
35. Wang Y, Tao L, Yuan Y., et al. Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action. Am J Physiol Endocrinol Metab 2009; 297:E384-E391
36. Penna C, Granata R, Tocchetti C.G., Gallo MP, Alloatti G, Pagliaro P. Endogenous cardioprotective agents: role in pre and postconditioning. Curr Drug Targets 2015; 16:843-867
37. Wang Y, Lau WB, Gao E, et al Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2010; 298:E663-E670
38. Kersten JR, Toller WG, Gross E.R., Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 2000; 278:H1218-H1224
39. Hotta K, Funahashi T, Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20:1595-1599
40. Wang T, Qiao S, Lei S., et al. N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS One 2011; 6:e23967
41. Kamigaki M, Sakaue S, Tsujino I., et al. Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2006; 339:624-632
42. Saraheimo M, Forsblom C, Fagerudd J., et al.; FinnDiane Study Group. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005; 28:1410-1414
43. Lindström T., Frystyk J, Hedman C.A., Flyvbjerg A., Arnqvist HJ. Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Clin Endocrinol (Oxf) 2006; 65:776-782
44. Zhu SG, Xi L, Kukreja RC Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase δ and Echs1. J Cell Mol Med 2012; 16:950-958
45. Omar MA, Fraser H, Clanachan AS Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete isolated working rat hearts. Am J Physiol Heart Circ Physiol 2008; 294:H1266-H1273
46. Folmes CD, Clanachan AS, Lopaschuk GD Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 2006; 99:61-68
47. Okada-Iwabu M., Yamauchi T, Iwabu M., et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 2013; 503:493-499